Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126998361 | 12699836 | 1 | I | 20160824 | 20160830 | 20160830 | EXP | US-MYLANLABS-2016M1036589 | MYLAN | YEO KK, HADUONG JH. THE USE OF CONTINUOUS VENO-VENOUS HEMODIAFILTRATION IN THE MANAGEMENT OF IFOSFAMIDE-INDUCED ENCEPHALOPATHY: A CASE REPORT. J-PEDIATR-HEMATOL-ONCOL 2016;38(6):489-490. | 0.00 | Y | 0.00000 | 20160830 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126998361 | 12699836 | 1 | PS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | 2000MG/M2/DOSE RUN OVER 1 HOUR EACH DAY, 3 DOSES OVER 3 DAYS | Y | U | 201689 | ||||||||
| 126998361 | 12699836 | 2 | C | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | DOSED USING AN AUC OF 6 | 0 | ||||||||||
| 126998361 | 12699836 | 3 | C | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126998361 | 12699836 | 1 | Neuroblastoma recurrent |
| 126998361 | 12699836 | 2 | Neuroblastoma recurrent |
| 126998361 | 12699836 | 3 | Neuroblastoma recurrent |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126998361 | 12699836 | LT |
| 126998361 | 12699836 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126998361 | 12699836 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |